ADVANCED
Clinical trials for ADVANCED explained in plain language.
Never miss a new study
Get alerted when new ADVANCED trials appear
Sign up with your email to follow new studies for ADVANCED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stomach cancer: immune booster combo trial launches
Disease control Not yet recruitingThis study tests a new drug combination for people with advanced stomach cancer that has worsened after initial treatment. The experimental drug IBI363 aims to help the immune system attack cancer cells, and is given with bevacizumab, with or without nab-paclitaxel. About 50 adul…
Matched conditions: ADVANCED
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for advanced GIST: experimental drug NB003 enters Late-Stage trial
Disease control Not yet recruitingThis study tests a new drug called NB003 in people with advanced GIST (a type of stomach or intestinal cancer) that has worsened after standard treatments. The trial has two parts: one compares NB003 to another drug (regorafenib) for patients who have already tried two prior ther…
Matched conditions: ADVANCED
Phase: PHASE2, PHASE3 • Sponsor: Ningbo Newbay Technology Development Co., Ltd • Aim: Disease control
Last updated May 13, 2026 15:59 UTC